| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 03/16/2006 | US20060058304 Azaindole kinase inhibitors |
| 03/16/2006 | US20060058302 Antiinflammatory agents; osteoporosis; rheumatic diseases; autoimmune diseases; example compound: 2-Chloro-5-(3,5-dioxo-4,5-dihydro-3H-[1,2,4]triazin-2-yl)-N-(2-ethyl-hexyl)-benzamide |
| 03/16/2006 | US20060058288 Severe sepsis preventive therapeutic agent |
| 03/16/2006 | US20060058244 New pyrazole derivatives and diabetic medicine containing them |
| 03/16/2006 | US20060057663 Novel g protein-coupled receptor protein and dna thereof |
| 03/16/2006 | US20060057648 Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (nmu1) |
| 03/16/2006 | US20060057254 Zinc-rich foods having effect of preventing diabetes |
| 03/16/2006 | US20060057252 Composition containing calcium pantothenate and vitamin |
| 03/16/2006 | US20060057156 Materials and methods for inductions of immune tolerance |
| 03/16/2006 | US20060057137 Glp-1 and methods for treating diabetes |
| 03/16/2006 | DE102005032094A1 Gemisch zur Verringerung von Blutfett Mixture to reduce blood fat |
| 03/16/2006 | DE102004044221A1 Neue 3-Methyl-7-butinyl-xanthine, deren Herstellung und deren Verwendung als Arzneimittel New 3-methyl-xanthine-7-butynyl, their preparation and their use as medicaments |
| 03/16/2006 | DE102004038328A1 Neue Verwendungen von 2-Phenyl-substituierten Imidazotriazinon-Derivaten New uses of 2-phenyl-substituted derivatives imidazotriazinone |
| 03/16/2006 | DE102004038270A1 Substituierte, bizyklische 8-Amino-xanthine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Substituted bicyclic 8-amino-xanthine, processes for their preparation and their use as medicaments |
| 03/16/2006 | DE102004038269A1 Substituierte, bizyklische 8-Piperidino-xanthine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Substituted bicyclic 8-piperidino xanthine, processes for their preparation and their use as medicaments |
| 03/16/2006 | DE102004037554A1 Substituierte 8-Aminoalkylthio-xanthine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Substituted 8-aminoalkylthio-xanthines, processes for their preparation and their use as medicaments |
| 03/16/2006 | CA2579621A1 Substituted piperazine compounds and their use as fatty acid oxidation inhibitors |
| 03/16/2006 | CA2579204A1 Carbamoyl-substituted spiro derivative |
| 03/16/2006 | CA2578958A1 Acetylated starch or starch succinate for treatment of obesity or diabetes |
| 03/16/2006 | CA2578952A1 Waxy corn starch and use thereof for treating obesity and diabetes |
| 03/16/2006 | CA2578933A1 Phenanthridine carbonyl phenols as cytokine modulators |
| 03/16/2006 | CA2578290A1 Combination of organic compounds |
| 03/16/2006 | CA2578049A1 Delta 6-desaturase genes and uses thereof |
| 03/16/2006 | CA2577408A1 Use of (halobenzyloxy) benzylamino-propanamides for the manufacture of medicaments active as sodium and/or calcium channel selective modulators |
| 03/16/2006 | CA2575751A1 8-(3-amino-piperidin-1-yl)-7-(but-2-inyl)-xanthines, production thereof and use thereof as medicaments |
| 03/15/2006 | EP1634951A1 Novel protein |
| 03/15/2006 | EP1634876A2 Heterocyclic compounds for the treatment of hyperlipidemia agents |
| 03/15/2006 | EP1634605A2 Treatment of dyslipidemia in a patient having type 2 diabetes |
| 03/15/2006 | EP1634594A1 Use of 3-substituted oxindole derivatives as KCNQ potassium channel modulators |
| 03/15/2006 | EP1634593A2 Hypoglycemics comprising organic zinc (II) complexes |
| 03/15/2006 | EP1634592A2 Hypoglycemics comprising organic zinc (II) complexes |
| 03/15/2006 | EP1634591A2 Hypoglycemics comprising organic zinc (II) complexes |
| 03/15/2006 | EP1634498A2 Exo-S-mecamylamine formulation |
| 03/15/2006 | EP1633883A1 Method for assaying lkb1 phosphorylation activity |
| 03/15/2006 | EP1633751A1 Carboline and betacarboline derivatives for use as hdac enzyme inhibitors |
| 03/15/2006 | EP1633747A1 Tetrahydroisoquinoline derivatives as ppar-a activators |
| 03/15/2006 | EP1633393A1 Use of a clostridial toxin to reduce appetite |
| 03/15/2006 | EP1633392A2 Vector for oral administration |
| 03/15/2006 | EP1633377A1 A method of treating or preventing chronic wounds and a complete nutritional composition comprising glycine and/or leucine for use therein |
| 03/15/2006 | EP1633375A1 Combination consisting of a magnesium preparation having a prolonged release and of another active substance, and use thereof in the fields of cosmetics, therapeutics and/or nutrition |
| 03/15/2006 | EP1633354A2 N-(((((1,3-thiazol-2-yl)amino)carbonyl)phenyl)sulfonyl)phenylalanine derivatives and related compounds for the treatment of diabetes |
| 03/15/2006 | EP1633351A1 5-substituted 2h-pyrazole-3-carboxylic acid derivatives as agonists for the nicotinic acid receptor rup25 for the treatment of dyslipidemia and related diseases |
| 03/15/2006 | EP1633340A2 Compounds for the treatment of metabolic disorders |
| 03/15/2006 | EP1513834B1 Substituted thiophenes, method for the production thereof, their use as a medicament or diagnostic reagent, and a medicament containing the same |
| 03/15/2006 | EP1465864B1 Inhibitors of factor xa and other serine proteases involved in the coagulation cascade |
| 03/15/2006 | EP1461040B1 Succinic acid salts of 5,8,14-triazatetracyclo[10.3.1.0 2,11 .0 4,9 ]-hexadeca-2(11),3,5,7,9,-pentaene and pharmaceutical compositions thereof |
| 03/15/2006 | EP1451577A4 Soluble cd40l(cd154) as a prognostic marker of atherosclerotic diseases |
| 03/15/2006 | EP1448566B1 Chemokine receptor antagonists and methods of use thereof |
| 03/15/2006 | EP1404303A4 Stable pharmaceutical compositions containing pravastatin |
| 03/15/2006 | EP1331937B1 Dibenzoxazepine alpha v integrin receptor antagonist |
| 03/15/2006 | EP1326864B1 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 03/15/2006 | EP1309589B1 Urea compounds and methods of uses |
| 03/15/2006 | EP1254209B1 Composition comprising hydroxycitric acid and garcinol for weight-loss |
| 03/15/2006 | EP1196172B1 (S,S)-Reboxetine for treating chronic pain |
| 03/15/2006 | EP1129078B1 Indazole derivatives with 5-ht2 receptor activity |
| 03/15/2006 | EP0939590B1 Nucleic acids for use in gene therapy involving intestinal cell gene expression |
| 03/15/2006 | CN1747955A Nitrogen-substituted hexahydropyrazino[1,2-a]pyrimidine-4,7-dione derivatives, method for the production and use thereof as medicaments |
| 03/15/2006 | CN1747771A Method of reducing impurity content in aqueous salt solution |
| 03/15/2006 | CN1747739A The use of lupin conglutin for the treatment of type ii diabetes |
| 03/15/2006 | CN1747727A Inhibitor for perioperative blood sugar elevation |
| 03/15/2006 | CN1747661A Preparation and food product comprising an active phytase |
| 03/15/2006 | CN1746190A Modified peptides as therapeutic agents |
| 03/15/2006 | CN1746189A Modified peptides as therapeutic agents |
| 03/15/2006 | CN1746188A Analog of GLP-1 |
| 03/15/2006 | CN1746185A Analog of Exendin 4 |
| 03/15/2006 | CN1746164A Protein antagonist with water channel |
| 03/15/2006 | CN1745835A Diabetes mellitus pill and prescription thereof |
| 03/15/2006 | CN1745817A Medicine for treating cerebral arteriosclerosis |
| 03/15/2006 | CN1745810A Chinese medicinal pill for treating diabetes mellitus |
| 03/15/2006 | CN1745809A Liuwei Dihuang effervescent tablet and its preparation thereof |
| 03/15/2006 | CN1745803A Longxuejie extract with alpha-glycosidase inhibiting activity and its quality control |
| 03/15/2006 | CN1745798A Granular preparation with pure Chinese medicine for treating hypertension and hyperlipemia and arterial sclerosis |
| 03/15/2006 | CN1745792A Compound Chinese medicine for regulating blood fat and blood sugar |
| 03/15/2006 | CN1745787A Compound Chinese medicine for treating hyperlipemia |
| 03/15/2006 | CN1245495C Pagodatree flower healthcare liquor and its preparation method |
| 03/15/2006 | CN1245417C Prodrugs of dipeptidyl peptidase IV inhibitors |
| 03/15/2006 | CN1245412C Method for producing highly pure acarbose |
| 03/15/2006 | CN1245405C Piperazine derivatives |
| 03/15/2006 | CN1245402C Indole derivatives, their preparation, medicinal compositions containing them and use thereof |
| 03/15/2006 | CN1245394C Substituted phenylacetamides and their use as glucokinase activators |
| 03/15/2006 | CN1245385C Indole and dihydroindole derivatives |
| 03/15/2006 | CN1245203C Blood sugar reducing tablet |
| 03/15/2006 | CN1245199C Oral medicinal composition for treating diabetes |
| 03/15/2006 | CN1245198C Chinese medicine composition for treating diabetes and its preparing method |
| 03/15/2006 | CN1245170C Health care composition for preventing and treating cadiac vascular diseases and its use |
| 03/15/2006 | CN1245164C Cell growth regulating factor oral liquid and its preparation process |
| 03/15/2006 | CN1245158C 片剂组合物 Tablet composition |
| 03/15/2006 | CN1245157C Novel fatty derivative for treatment of diabetes |
| 03/15/2006 | CN1245153C Vitamin A liposome and its preparation method |
| 03/14/2006 | US7012146 Modulators of all three classes of calcium channel blocker subtypes (Small, Intermediate and Big conductance K channel (SK, IK and BK)) comprising malonate esters and nitriles; respiratory, brain, cardiovascular, urogenital disorders |
| 03/14/2006 | US7012099 Use of substituted 4-amino-1-phenylbutan-2-ol compounds as medicaments |
| 03/14/2006 | US7012089 Administering to a patient suffering from psychological disoders a (1,4)diazocino(7,7,1-hi)inodle derivative as 5HT2c agonist or partial agonist |
| 03/14/2006 | US7012085 As antipsychotics in therapy of schizophrenia, depression, bipolar disorders, cognition deficits, Parkinson disease, drug abuse, attention deficit hyperactivity disorders, glaucoma, diabetes and erectile dysfunction |
| 03/14/2006 | US7012084 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 03/14/2006 | US7012077 Anticholesterol agents; antilipemic agents |
| 03/14/2006 | US7012073 Quinoline derivatives |
| 03/14/2006 | US7012071 such as 4-(4-(2-Fluorobenzyloxy)phenyl)-4-oxobutyric acid; for treatment of insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis |
| 03/14/2006 | US7012069 For therapy of heart disease and stroke, Alzheimer's disease, and an inflammatory disorder |
| 03/14/2006 | US7012067 Synergistic mixture containing simvastatin |
| 03/14/2006 | CA2521953C Crystalline forms of [r-(r*,r*)]-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid calcium salt (2:1) (atorvastatin) |